Cu(II) and Co(II) ternary complexes of quinolone antimicrobial drug enoxacin and levofloxacin: structure and biological evaluation
暂无分享,去创建一个
[1] B. Turk,et al. New uses for old drugs: attempts to convert quinolone antibacterials into potential anticancer agents containing ruthenium. , 2013, Inorganic chemistry.
[2] I. Turel,et al. Zinc(II) complexes with the quinolone antibacterial drug flumequine: structure, DNA- and albumin-binding , 2013 .
[3] I. Turel,et al. Different types of copper complexes with the quinolone antimicrobial drugs ofloxacin and norfloxacin: structure, DNA- and albumin-binding. , 2012, Journal of inorganic biochemistry.
[4] I. Turel,et al. Copper(II) complexes with antimicrobial drug flumequine: structure and biological evaluation. , 2012, Journal of inorganic biochemistry.
[5] L. Cunha-Silva,et al. Synthesis, characterization and antibacterial studies of a copper(II) levofloxacin ternary complex. , 2012, Journal of inorganic biochemistry.
[6] Jingquan Sha,et al. Nickel complexes of the different quinolone antibacterial drugs: Synthesis, structure and interaction with DNA , 2012 .
[7] Hong Liang,et al. TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA. , 2012, Inorganic chemistry.
[8] I. Turel,et al. Nickel-quinolones interaction. Part 5-Biological evaluation of nickel(II) complexes with first-, second- and third-generation quinolones. , 2011, Journal of inorganic biochemistry.
[9] I. Turel,et al. Interaction of Zn(II) with quinolone drugs: structure and biological evaluation. , 2011, Dalton transactions.
[10] N. Osheroff,et al. First ruthenium organometallic complex of antibacterial agent ofloxacin. Crystal structure and interactions with DNA. , 2010, Inorganic chemistry.
[11] E. Pereira,et al. Solution and biological behaviour of enrofloxacin metalloantibiotics: a route to counteract bacterial resistance? , 2010, Journal of inorganic biochemistry.
[12] A. Terzis,et al. Zinc(II) complexes of the second-generation quinolone antibacterial drug enrofloxacin: Structure and DNA or albumin interaction. , 2010, Bioorganic & medicinal chemistry.
[13] V. Charushin,et al. Metallocomplexes of fluoroquinolonecarboxylic acids , 2009 .
[14] A. Terzis,et al. Nickel-quinolones interaction. Part 1 - Nickel(II) complexes with the antibacterial drug sparfloxacin: structure and biological properties. , 2009, Journal of inorganic biochemistry.
[15] Min-sheng Liu,et al. Synthesis, characterization, DNA binding properties, and biological activities of a mixed ligand copper(II) complex of ofloxacin , 2009 .
[16] Liang-cai Yu,et al. Syntheses and crystal structures of Zn(II) and Co(II) complexes with ofloxacin and enoxacin , 2009 .
[17] A. Stańczak,et al. The complexes of metal ions with fluoroquinolones , 2009 .
[18] P. Yi,et al. Hydrothermal syntheses, crystal structures and antibacterial activities of two transition metal complexes with ciprofloxacin , 2009 .
[19] M. Liu-González,et al. Synthesis, structure and biological properties of several binary and ternary complexes of copper(II) with ciprofloxacin and 1,10 phenanthroline , 2009 .
[20] Jessina C. McGregor,et al. Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis , 2008, Therapeutics and clinical risk management.
[21] P. Yi,et al. Hydrothermal syntheses, crystal structures and antibacterial activities of two Cu(II) complexes with quinolones , 2008 .
[22] D. Vourloumis,et al. Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities. , 2008, Journal of medicinal chemistry.
[23] Robert R. Crichton,et al. Biological inorganic chemistry : an introduction , 2008 .
[24] Yan-Cheng Liu,et al. Synthesis, crystal structure of polyoxovanadate complex of ciprofloxacin: V4O10(μ2-O)2[VO(H-Ciprof)2]2 · 13H2O by hydrothermal reaction , 2007 .
[25] V. S. Periasamy,et al. Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity. , 2007, Inorganic chemistry.
[26] Yanqing Wang,et al. Interaction of the flavonoid hesperidin with bovine serum albumin: A fluorescence quenching study , 2007 .
[27] R. Gust,et al. Influence of the Polypyridyl (pp) Ligand Size on the DNA Binding Properties, Cytotoxicity and Cellular Uptake of Organoruthenium(II) Complexes of the Type [(η6‐C6Me6)Ru(L)(pp)]n+ [L = Cl, n = 1; L = (NH2)2CS, n = 2] , 2007 .
[28] F. Sarkar,et al. Neutral dimeric copper–sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line , 2007 .
[29] E. Efthimiadou,et al. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: synthesis, structure and bioactivity. , 2007, Journal of inorganic biochemistry.
[30] C. Raptopoulou,et al. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid. , 2006, Journal of inorganic biochemistry.
[31] E. Sletten,et al. X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones - racemic ofloxacin and its S-form, levofloxacin. , 2006, Journal of inorganic biochemistry.
[32] Yingmei Liu,et al. DNA Binding and cleavage activity of Ni(II) complex with all-trans retinoic acid. , 2006, Journal of inorganic biochemistry.
[33] C. Raptopoulou,et al. Neutral and cationic mononuclear copper(II) complexes with enrofloxacin: structure and biological activity. , 2006, Journal of inorganic biochemistry.
[34] C. Raptopoulou,et al. Crystal structure, spectroscopic, and biological study of the copper(II) complex with third-generation quinolone antibiotic sparfloxacin. , 2006, Bioorganic & medicinal chemistry letters.
[35] L. Mitscher. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. , 2005, Chemical reviews.
[36] Yi Liu,et al. Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. , 2004, Journal of pharmaceutical and biomedical analysis.
[37] G. Song,et al. The Interaction Between Levofloxacine Hydrochloride and DNA Mediated by Cu2+ , 2004, Journal of Fluorescence.
[38] A. Powell,et al. A novel mixed-ligand antimycobacterial dimeric copper complex of ciprofloxacin and phenanthroline. , 2004, Bioorganic & medicinal chemistry letters.
[39] H. Ju,et al. A mononuclear complex of norfloxacin with silver(I) and its properties , 2003 .
[40] Longguan Zhu,et al. Synthesis, Crystal Structure, Stacking Effect and Antibacterial Studies of a Novel Quaternary Copper (II) Complex with Quinolone , 2003, Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry.
[41] M. Villa,et al. Complexes of Co(II) and Zn(II) with ofloxacin. Crystal structure of [Co(oflo)2(MeOH)2].4MeOH. , 2002, Journal of pharmaceutical sciences.
[42] I. Turel. The interactions of metal ions with quinolone antibacterial agents , 2002 .
[43] S. García‐Granda,et al. Interactions of metal ions with two quinolone antimicrobial agents (cinoxacin and ciprofloxacin). Spectroscopic and X-ray structural characterization. Antibacterial studies. , 2002, Journal of inorganic biochemistry.
[44] M. Villa,et al. Complexes of Ni(II) and Cu(II) with ofloxacin. Crystal structure of a new Cu(II) ofloxacin complex. , 2001, Journal of inorganic biochemistry.
[45] L. Messori,et al. Interactions of selected gold(III) complexes with calf thymus DNA. , 2001, Biochemical and biophysical research communications.
[46] H. Tomioka,et al. Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. , 2000, International journal of antimicrobial agents.
[47] J. Robles,et al. A Theoretical-Experimental Study on the Structure and Activity of Certain Quinolones and the Interaction of Their Cu(II)-Complexes on a DNA Model , 2000, Metal-based drugs.
[48] D. Hooper. Clinical applications of quinolones. , 1998, Biochimica et biophysica acta.
[49] Y. Chen,et al. Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl]+ units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding. , 1998, Journal of inorganic biochemistry.
[50] C. Raptopoulou,et al. CuII-herbicide complexes: structure and bioactivity , 1998 .
[51] L. Gahan,et al. Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dog. , 1996, Journal of pharmaceutical sciences.
[52] P. Sadler. Inorganic Chemistry and Drug Design , 1991 .
[53] W. Kohlbrenner,et al. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. , 1989, The Journal of biological chemistry.
[54] D. McConnell,et al. A study of the interactions of some polypyridylruthenium (II) complexes with DNA using fluorescence spectroscopy, topoisomerisation and thermal denaturation. , 1985, Nucleic acids research.
[55] N. Turro,et al. Photophysics of ruthenium complexes bound to double helical DNA , 1985 .
[56] A. W. Addison,et al. Synthesis, structure, and spectroscopic properties of copper(II) compounds containing nitrogen–sulphur donor ligands; the crystal and molecular structure of aqua[1,7-bis(N-methylbenzimidazol-2′-yl)-2,6-dithiaheptane]copper(II) perchlorate , 1984 .
[57] N. Cozzarelli. DNA gyrase and the supercoiling of DNA. , 1980, Science.
[58] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .
[59] S. Rice,et al. A Further Examination of the Molecular Weight and Size of Desoxypentose Nucleic Acid , 1954 .